Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Duca

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Current Topics in Medicinal Chemistry|March 16, 2016
Implications of Dynamic Occupancy, Binding Kinetics, and Channel Gating Kinetics for hERG Blocker Safety Assessment and MitigationRobert A Pearlstein, K Andrew MacCannell, Gül Erdemli, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitorsXiaohua Huang, Cliff C Cheng, Thierry O Fischmann, et al.
Biopolymers|October 17, 2007
Structure-guided discovery of cyclin-dependent kinase inhibitorsThierry O Fischmann, Alan Hruza, José S Duca, et al.
Nature Reviews. Drug Discovery|December 6, 2019
Rethinking drug design in the artificial intelligence eraPetra Schneider, W Patrick Walters, Alleyn T Plowright, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main proteaseAnna Pavlova, Diane L Lynch, Isabella Daidone, et al.
Chemical Science|March 31, 2022
Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main proteaseAnna Pavlova, Diane L Lynch, Isabella Daidone, et al.
Journal of the American Society of Nephrology : JASN|May 21, 2013
LMX1B mutations cause hereditary FSGS without extrarenal involvementOlivia Boyer, Stéphanie Woerner, Fan Yang, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitorQingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Current Topics in Medicinal Chemistry|March 16, 2016
Implications of Dynamic Occupancy, Binding Kinetics, and Channel Gating Kinetics for hERG Blocker Safety Assessment and MitigationRobert A Pearlstein, K Andrew MacCannell, Gül Erdemli, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitorsXiaohua Huang, Cliff C Cheng, Thierry O Fischmann, et al.
Biopolymers|October 17, 2007
Structure-guided discovery of cyclin-dependent kinase inhibitorsThierry O Fischmann, Alan Hruza, José S Duca, et al.
Nature Reviews. Drug Discovery|December 6, 2019
Rethinking drug design in the artificial intelligence eraPetra Schneider, W Patrick Walters, Alleyn T Plowright, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main proteaseAnna Pavlova, Diane L Lynch, Isabella Daidone, et al.
Chemical Science|March 31, 2022
Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main proteaseAnna Pavlova, Diane L Lynch, Isabella Daidone, et al.
Journal of the American Society of Nephrology : JASN|May 21, 2013
LMX1B mutations cause hereditary FSGS without extrarenal involvementOlivia Boyer, Stéphanie Woerner, Fan Yang, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitorQingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.
Pageof 14